title: Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.
authors: Hiroto
authors: H
authors: Inaba
authors: Deepa
authors: D
authors: Bhojwani
authors: Jennifer L
authors: JL
authors: Pauley
authors: Deqing
authors: D
authors: Pei
authors: Cheng
authors: C
authors: Cheng
authors: Monika L
authors: ML
authors: Metzger
authors: Scott C
authors: SC
authors: Howard
authors: Jeffrey E
authors: JE
authors: Rubnitz
authors: John T
authors: JT
authors: Sandlund
authors: Raul C
authors: RC
authors: Ribeiro
authors: Wing
authors: W
authors: Leung
authors: Dario
authors: D
authors: Campana
authors: Ching-Hon
authors: CH
authors: Pui
authors: Sima
authors: S
authors: Jeha
mesh_terms: D000227:Adenine Nucleotides / Q000008:administration & dosage; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D000077866:Clofarabine; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D005047:Etoposide; D000077866:Clofarabine; D003520:Cyclophosphamide